PhD student Translational Gastrointestinal Oncology
You cannot apply for this job anymore (deadline was 11 Dec ’22)
We are looking for a PhD student in the field of translational gastrointestinal oncology. Liquid biopsies contain minute amounts of cell-free circulating tumor DNA (ctDNA) in blood plasma, derived from primary and metastatic lesions. The aim of the PLCRC-DOLPHIN study is to examine how ctDNA testing can complement or partly replace CT imaging for treatment response monitoring of patients with metastatic colorectal cancer.
Academic fields
Health
Job types
PhD
Education level
University graduate
Weekly hours
36 hours per week
Salary indication
€2972—€3620 per month
The DOLPHIN project is an international multidisciplinary public private partnership project lead by Remond Fijneman (Translational Gastrointestinal Oncology, NKI) in close collaboration with Niels Kok (Surgery, NKI), Max Lahaye (Radiology, NKI), Jeanine Roodhart (Medical Oncology, UMCU), Manon Braat (Radiology, UMCU), Geraldine Vink (UMCU and PLCRC), Veerle Coupé (Health Technology Assessment, AUMC) and the company Delfi Diagnostics (Baltimore, USA).
You will coordinate the DOLPHIN study, which makes use of the infrastructure of the Dutch Prospective ColoRectal Cancer cohort study PLCRC. You will bring together clinical, imaging and molecular data and investigate the clinical utility of ctDNA testing for treatment response monitoring in patients with metastatic colorectal cancer.
Fixed-term contract: 4 years.
You will join a dynamic international research team and will collaborate with clinicians and scientists with expertise in different disciplines. You will have the opportunity to follow high-quality courses offered by the OOA oncology graduate school throughout your PhD.
Your temporary employment will be for a period of four years. The gross salary per month will be according to the standard PhD scales starting from €2972,- to a maximum of €3620,- . The salary will depends on previous experience. The terms of employment will be in accordance with the CAO Ziekenhuizen (Collective Labour Agreement for Hospitals).
The Netherlands Cancer Institute is among the world’s best comprehensive cancer centers, combining innovative fundamental, translational, and clinical research with dedicated patient care. Our research institute gratefully acknowledges funding from the Dutch Ministry of Health, Welfare and Sport, the Dutch Cancer Society, and individual donors. Read more about us.